Company Name: Avexis Inc.

Avexis Inc. is a clinical stage gene therapy company. The company is engaged in the development of treatments for rare neurological genetic diseases. The company’s initial gene therapy product candidate is a treatment for spinal muscular atrophy (SMA) Type 1. The company is initially targeting SMA Type 1 but intends to target other SMA subtypes.   

Ticker Symbol: AVXS (NASDAQ)

Company Website:

Social Media: Avexis LinkedIn

Headquarters: Bannockburn, Illinois